Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
IMMUNOMONITOR project–Ultimovacs: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response cancer vaccines 2018-07-05
IMMUNOMONITOR project–Univ Hamburg: pharmacogenomics, 201807– collab partner Eurostars in project develop validation treatm response cancer vaccines 2018-07-05
Basilea–Coulter Partners: recruitment services, 201807 supply service placement of Gerrit Hauck as new CTO of Basilea Pharmaceutica Intl Ltd 2018-07-04
Lactotronic–Bruker Corp: investment, 201807 acquisition €na of Lactotronic BV by Bruker 2018-07-03
Novartis–France (govt): cell therapy contract manufacturing, 201807– supply production CAR-T cell therapies incl Kymriah by CellforCure 2018-07-01
NBE Therapeutics–Novo Group: investment, 201806 financing round Series B CHF20m extension by Novo Holdings bringing total Series B to CHF40m 2018-06-28
Bruker Corp–Cytosurge: cell analysis technology, 201806 collab product integration FluidFM techn on BioScope Resolve AMF for single cell analysis 2018-06-27
Nouscom–Minapharm: cell line, 201806– license to ProBioGen’s AGE1.CR duck cell line for production of viral vectored vaccines 2018-06-26
Exosome Diagnostics–Bio-Techne: investment, 201806– acquisition $250m cash + $325m milestones of Exosome Dx by Bio-Techne ANNOUNCED 2018-06-25
Exosome Diagnostics–Goodwin Procter: legal services, 201806 supply service legal counsel with regard to acquisition of Exosome Dx by Bio-Techne Corp 2018-06-25
Exosome Diagnostics–Moelis: financial services, 201806 supply service financial advisor with regard to acquisition of Exosome Dx by Bio-Techne Corp 2018-06-25
Univ Missouri–Bruker Corp: mass spectrometer, 201806 supply existent timsTOF Pro system at Univ of Missouri in Columbia MO 2018-06-25
Evonik–BRAIN: industrial biotechnology, 201806– collab with CyPlus to develop products for global mining industry 2018-06-20
iTeos Therapeutics–6 Dimensions Capital: investment, 201806 financing round Series B totalling €64m incl new + co-investor 6 Dimensions Capital 2018-06-20
iTeos Therapeutics–Belgium (govt): investment, 201806 financing round Series B totalling €64m incl existing + co-investor SFPI 2018-06-20
iTeos Therapeutics–Curative Ventures: investment, 201806 financing round Series B totalling €64m incl new + co-investor Curative Ventures 2018-06-20
iTeos Therapeutics–Fund+: investment, 201806 financing round Series B totalling €64m incl existing + co-investor Fund+ 2018-06-20
iTeos Therapeutics–HBM: investment, 201806 financing round Series B totalling €64m incl new + co-investor HBM Partners 2018-06-20
iTeos Therapeutics–MPM Capital: investment, 201806 financing round Series B totalling €64m incl new + lead investor MPM Capital 2018-06-20
iTeos Therapeutics–SEVERAL: investment, 201806 financing round Series B €64m led by MPM Capital 2018-06-20
iTeos Therapeutics–Univ Leuven: investment, 201806 financing round Series B totalling €64m incl existing + co-investor VIVES II 2018-06-20
iTeos Therapeutics–Wallonia (govt): investment, 201806 financing round Series B totalling €64m incl existing + co-investor SRIW 2018-06-20
TG Therapeutics–Novimmune: bispecific antibody, 201806– collab + excl license option ww for CD47/CD19 antibody NI-1701 (TG-1801) 2018-06-20
Foundation Medicine–Roche: investment, 201806–201807 acquisition all remaining shares for $2.4b in cash at $137/share 2018-06-19
UgiSense–SEVERAL: investment, 201806 second financing round 2018-06-19
Interactive Biosoftware–Sophia Genetics: investment, 201806 acquisition of IBS by Sophia Genetics 2018-06-16
Noxxon–SEVERAL: credit, 201806– convertible bond €380k from existing investors 2018-06-15
Sanofi–Evotec: investment, 201806–201807 acquisition integration of Sanofi’s infectious disease RnD in Lyon into Evotec 2018-06-15
Deinove–SEVERAL: investment, 201806 capital increase €8.5m with 3.148 new shares at €2.7/share 2018-06-14
Andrew Alliance–Omega Advisors: investment, 201806 financing round Series C totalling $14m incl Omega Funds 2018-06-12
Andrew Alliance–SEVERAL: investment, 201806 financing round Series C $14m incl Tecan + Waters + Inpeco + Rancilio Cube + Sam Eletr + Omega Funds 2018-06-12
Andrew Alliance–Tecan: investment, 201806 financing round Series C totalling $14m incl Tecan Group 2018-06-12
Andrew Alliance–Waters: investment, 201806 financing round Series C totalling $14m incl Waters Corp 2018-06-12
Sartorius–Siemens: automation technology, 201806– collab long-term using Siemens automation for SSB’s bio production offerings 2018-06-12
Univ Jena–ACD/Labs: cheminformatics, 201806 supply ACD/Spectrus Processor + ACD/NMR Workbook Suite + ACD/MS Workbook Suite 2018-06-12
Univ Jena–Bruker Corp: mass spectrometer, 201806 supply existent 2018-06-12
Univ Jena–Shimadzu: mass spectrometer, 201806 supply existent 2018-06-12
Univ Jena–Thermo Fisher: mass spectrometer, 201806 supply existent 2018-06-12
RSP Systems–SEVERAL: investment, 201806 financing round Series B first closing €6.5m incl family offices + private investors 2018-06-11
Roche–Microbiotica: microbiomics, 201806– collab multi-year up to $534m r+d + commerc of markers + targets + treatments for IBD w Genentech 2018-06-06
Roivant–Oxford BioMedica: Parkinson’s gene therapy, 201806– license ww excl to OXB-102 $30m upfront + $812.5m milestones to Axovant Sciences 2018-06-06
Gilead–Hookipa: therapeutic vaccine technology, 201806– collab + license $10m upfront r+d immunotherapies against HIV + HBV 2018-06-05
Secarna–MC Services: public relations, 201806 service existent by MC Services 2018-06-04
Sierra Sensors–Bruker Corp: investment, 201806 acquisition €na of Sierra Sensors GmbH by Bruker 2018-06-04
Univ Birmingham–Thermo Fisher: mass spectrometer, 201806 supply existent early customer Orbitrap ID-X Tribrid MS system at PCB 2018-06-04
Univ Greifswald–Bruker Corp: NMR spectrometer, 201806 supply installation of AVANCE IVDr at Greifswald Univ Hospital) 2018-06-01
Arix Bioscience–Evotec: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutchinson Cancer Center 2018-05-31
Arix Bioscience–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Evotec 2018-05-31
Evotec–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Arix Bioscience 2018-05-31
TxCell–Lonza: cell therapy contract manufacturing, 201805– supply of TX200 for clinical studies by Lonza production site in Geleen (NL) 2018-05-31
Univ Tübingen–ERS Genomics: CRISPR technology, 201804– license €na to NMI + NMI TT Pharmaservices to expand custom cell-based research services 2018-05-31
F-Star–Denali Therapeutics: investment, 201805 acquisition of F-Star Gamma Ltd via early exercise of option for asset-centric vehicle 2018-05-30
Five Prime–Roche: companion diagnostics, 201805– collab €na to develop IHC CDx assays for two cancer antibody candidates 2018-05-30
Ultra Scientific–Agilent: investment, 201805– acquisition of all business assets €na of Ultra Scientific by Agilent 2018-05-30
Aldeyra Therapeutics–Centogene: genomic services, 201805– collab identification of genetic markers for Sjögren-Larsson Syndrome using CentoMD 2018-05-29
Celgene–Evotec: drug discovery services, 201805– strategic RnD collab expansion $6m to incl additional cell lines 2018-05-29
High-Tech Gründerfonds–Bayer: investment, 201805 Bayer invests in HTGF III 2018-05-29
High-Tech Gründerfonds–Boehringer: investment, 201805 BIVF invests in HTGF III 2018-05-29
High-Tech Gründerfonds–SEVERAL: investment, 201805 2nd closing of HTGF III €71.5m bringing total fund size to €316.5m 2018-05-29
Treeway–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-29
Lunaphore–Vitro (ES): in situ hybridisation, 201805– collab developm ISH protocols for RNA + DNA targets in tissue 2018-05-24
Medigene–SEVERAL: investment, 201805 private placement €32.3m 2.23m new shares at €14.5/share to institutional investors 2018-05-24
Evotec–I’rom Group: iPSC technology, 201805– license non-excl for iPSCs produced with Sendai virus vector technology from ID Pharma 2018-05-23
Lava Therapeutics–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-23
Orphazyme–Centogene: biomarker discovery, 201805– collab service biomarkers for Gaucher disease clinical trial monitoring 2018-05-23
Samsung–Sphingotec: investment, 201805 acquisition of Nexus Dx Inc from Samsung via joint venture with CEO Nam Shin 2018-05-22
Celgene–Evotec: drug discovery services, 201805– strategic RnD collab $65m upfront for cancer drugs 2018-05-21
Pierre Fabre–Roche: companion diagnostics, 201805– collab extension for developm of IHC CDx assay for ADC W0101 2018-05-18
Acousia Therapeutics–Boehringer: investment, 201805 financing round Series B totalling €10m incl existing + co-investor BIVF 2018-05-14
Acousia Therapeutics–Bregua Corp: investment, 201805 financing round Series B totalling €10m incl new + co-investor Bregua Corp 2018-05-14
Acousia Therapeutics–Creathor Venture: investment, 201805 financing round Series B totalling €10m incl new + co-investor Creathor Venture 2018-05-14
Acousia Therapeutics–Germany (govt): investment, 201805 financing round Series B totalling €10m incl existing + co-investor KfW 2018-05-14
Acousia Therapeutics–Instinctif Partners: public relations, 201805 service existent by Instinctif 2018-05-14
Acousia Therapeutics–LBBW: investment, 201805 financing round Series B totalling €10m incl lead + new investor LBBW Venture Capital 2018-05-14
Acousia Therapeutics–SEVERAL: investment, 201805 financing round Series B €10m led by new investor LBBW Venture Capital 2018-05-14
Bluebird Bio–Medigene: TCR technology, 201805– collab strategic alliance expansion incl $8m one-time payment 2018-05-14
Polyneuron–SEVERAL: investment, 201805 seed financing round CHF3.1m led by EVA Basel + incl Zürcher Kantonalbank + private investors 2018-05-14
Valerius Biopharma–Catalent: contract manufacturing, 201805– collab cell line developm + manufacturing of speciality biosimilars using GPEx technology 2018-05-14
Armo BioSciences–Lilly: investment, 201805– acquisition $1.6b cash tender offer at $50/share by Eli Lilly 2018-05-10
Memo Therapeutics–Redalpine: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor Redalpine Venture Partners 2018-05-09
Memo Therapeutics–Schroders: investment, 201805 financing round Series A2 totalling CHF5m incl new investor Schroder Adveq 2018-05-09
Memo Therapeutics–SEVERAL: investment, 201805 financing round Series A2 CHF5m incl Schroder Adveq + investiere.ch + Redalpine Ventures et al. 2018-05-09
Memo Therapeutics–Verve Capital Partners: investment, 201805 financing round Series A2 totalling CHF5m incl new investor investiere.ch 2018-05-09
Memo Therapeutics–Zürcher Kantonalbank: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor ZKB 2018-05-09
PHAST–Eurofins: investment, 201805 acquisition of PHAST GmbH by Eurofins Scientific 2018-05-09
Bruker Corp–CMS: legal services, 201805 service legal advice by CMS on acquisition of Sierra Sensors GmbH by Bruker 2018-05-06
Bruker Corp–CMS: legal services, 201808 service legal advice by CMS on majority acquisition of Hain Lifescience by Bruker 2018-05-06
InflaRx–LifeSci: public relations, 201805 service existent IR by LifeSci Advisors + Media US by LifeSci Public Relations 2018-05-03
SmartDyeLivery–SEVERAL: investment, 201805 financing round from new investor STIFT + existing investors bm|t + Sparkasse Jena-Saale-Holzland 2018-05-03
Unisensor (BE)–Scienion: print/spotting technology, 201805 collab use of sciFlexarrayer techn for Extenso milk analysis platform 2018-05-03
Evotec–ERS Genomics: CRISPR technology, 201804– license €na to expand Evotec’s CRISPR-based service offering from ERS Genomics Ltd 2018-05-02
Genohm–Agilent: investment, 201805 acquisition €na of Genohm by Agilent 2018-05-02
InflaRx–SEVERAL: investment, 201805 primary public offering $51m+$7.65m w 1.5m+225k common shares at $34/share 2018-05-02
AdvanceCor–SEVERAL: investment, 201805 financing round €6m led by MIG AG + incl Occident Group + Bayern Kapital + HTGF + KfW Bank + founders 2018-05-01
Crescendo Biologics–SEVERAL: investment, 201805 financing round Series B €57m led by Andera Partners 2018-04-30
NovellusDx–SEVERAL: investment, 201804 financing round $6m incl investors Helsinn + BCIF + Windham Venture Partners 2018-04-30
Roche–4D Molecular Therapeutics: gene delivery technology, 201804– collab expansion to develop + commercialise ophthalmic gene therapy products 2018-04-30
Roivant–SEVERAL: investment, 201804 financing round $40.5m of Datavant led by Roivant Sciences + Travis May 2018-04-30
Universal Patient Key–Roivant: investment, 201804 acquisition of UPK by Datavant 2018-04-30
Curetis–Global Corporate Finance: investment, 201804–202103 equity facility $10m solely at Curetis request up to 36 months at pre-agreed floor pricing 2018-04-27
next pagenext page 1 2 3 4 5 6 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top